{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T01:54:33Z","timestamp":1789178073613,"version":"build-2803163510"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"51","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1097\/md.0000000000009186","type":"journal-article","created":{"date-parts":[[2017,12,21]],"date-time":"2017-12-21T21:41:16Z","timestamp":1513892476000},"page":"e9186","source":"Crossref","is-referenced-by-count":21,"title":["Infantile-onset Pompe disease with neonatal debut"],"prefix":"10.1097","volume":"96","author":[{"given":"Miriam","family":"Mart\u00ednez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar Garc\u00eda","family":"Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis Garc\u00eda","family":"Guereta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Cabrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita M.","family":"Regojo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Albajara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria L.","family":"Couce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel Saenz de","family":"Pipaon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-47-20210226","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.ncl.2014.04.010","article-title":"Pompe disease: literature review and case series","volume":"32","author":"Dasouki","year":"2014","journal-title":"Neurol Clin"},{"key":"R3-47-20210226","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/S0140-6736(08)61555-X","article-title":"Pompe's disease","volume":"372","author":"Van der Ploeg","year":"2008","journal-title":"Lancet"},{"key":"R4-47-20210226","first-page":"269","article-title":"Clinical guidelines for infantile-onset Pompe disease","volume":"63","author":"Pascual-Pascual","year":"2016","journal-title":"Rev Neurol"},{"key":"R5-47-20210226","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","article-title":"2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy. The Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC)","volume":"35","author":"Elliott","year":"2014","journal-title":"Eur Heart J"},{"key":"R6-47-20210226","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.jpeds.2014.10.068","article-title":"Long-term prognosis of patients with infantile-onset Pompe disease diagnosed by newborn screening and treated since birth","volume":"166","author":"Chien","year":"2015","journal-title":"J Pediatr"},{"key":"R7-47-20210226","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1212\/01.wnl.0000251268.41188.04","article-title":"Recombinant human acid [alpha]-glucosidase: major clinical benefits in infantile-onset Pompe disease","volume":"68","author":"Kishnani","year":"2007","journal-title":"Neurol"},{"key":"R8-47-20210226","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s10545-010-9206-3","article-title":"Treatment of infantile Pompe disease with alglucosidase alpha: the UK experience","volume":"33","author":"Chakrapani","year":"2010","journal-title":"J Inherit Metab Dis"},{"key":"R9-47-20210226","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1097\/GIM.0b013e3182174703","article-title":"The impact of antibodies on clinical outcomes in diseases treated with therapeutic protein: lessons learned from infantile Pompe disease","volume":"13","author":"Banugaria","year":"2011","journal-title":"Genet Med"},{"key":"R11-47-20210226","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ymgme.2013.08.010","article-title":"A new assay for fast, reliable CRIM status determination in infantile-onset Pompe disease","volume":"111","author":"Wang","year":"2014","journal-title":"Mol Genet Metab"},{"key":"R12-47-20210226","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/ped.13122","article-title":"Enzyme therapy for hypertrophic cardiomyopathy in non-classical Pompe disease: effectiveness of treatment","volume":"59","author":"Kim","year":"2017","journal-title":"Pediatr Int"},{"key":"R13-47-20210226","first-page":"210","article-title":"Clinical outcomes after long-term treatment with alglucosidase alfa in infants and children with advanced Pompe disease","volume":"11","author":"Nicolino","year":"2009","journal-title":"Neurol"},{"key":"R14-47-20210226","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1136\/heartjnl-2011-300531","article-title":"Hypertrophic cardiomyopathy in children","volume":"98","author":"Moak","year":"2012","journal-title":"Heart"},{"key":"R15-47-20210226","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3892\/etm.2015.2862","article-title":"Infantile Pompe disease: a case report and review of the Chinese literature","volume":"11","author":"Liu","year":"2016","journal-title":"Exp Ther Med"},{"key":"R16-47-20210226","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1542\/peds.2007-2222","article-title":"Early detection of Pompe disease by newborn screening is feasible: results from the Taiwan screening program","volume":"122","author":"Chien","year":"2008","journal-title":"Pediatrics"},{"key":"R17-47-20210226","first-page":"227","article-title":"Recurrence of Pompe disease in first cousins","volume":"26","author":"Lacombe","year":"2014","journal-title":"Genet Couns"},{"key":"R18-47-20210226","doi-asserted-by":"crossref","first-page":"e003637","DOI":"10.1161\/CIRCIMAGING.115.003637","article-title":"Giant heart of classical infantile-onset Pompe disease with mirror image dextrocardia","volume":"8","author":"Tripathi","year":"2015","journal-title":"Circ Cardiovasc Imaging"},{"key":"R19-47-20210226","doi-asserted-by":"crossref","first-page":"bcr2015210688","DOI":"10.1136\/bcr-2015-210688","article-title":"c.1437G>A intron 9 substitution on acid \u03b1-glucosidase gene associated with classic infantile-onset Pompe disease phenotype","volume":"2015","author":"Morales","year":"2015","journal-title":"BMJ Case Rep"},{"key":"R20-47-20210226","doi-asserted-by":"crossref","first-page":"503","DOI":"10.33588\/rn.5911.2014363","article-title":"Variabilidad en la presentaci\u00f3n cl\u00ednica de la enfermedad de Pompe infantil: presentaci\u00f3n de dos casos y respuesta al tratamiento con enzima recombinante humana","volume":"59","author":"Moreno Medinilla","year":"2014","journal-title":"Rev Neurol"},{"key":"R21-47-20210226","first-page":"1265","article-title":"Two novel mutations in acid \u03b1-glucosidase gene in two patients with Pompe disease","volume":"27","author":"Aykut","year":"2014","journal-title":"J Pediatr Endocrinol Metab"},{"key":"R22-47-20210226","doi-asserted-by":"crossref","first-page":"6211","DOI":"10.1007\/s11033-014-3500-3","article-title":"A newly identified c. 1824_1828dupATACG mutation in exon 13 of the GAA gene in infantile-onset glycogen storage disease type II (Pompe disease)","volume":"41","author":"Aryani","year":"2014","journal-title":"Mol Biol Rep"},{"key":"R23-47-20210226","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.gene.2013.12.033","article-title":"Novel GAA sequence variant c.1211 A>G reduces enzyme activity but not protein expression in infantile and adult onset Pompe disease","volume":"537","author":"Nilsson","year":"2014","journal-title":"Gene"},{"key":"R24-47-20210226","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00508-013-0475-3","article-title":"Effects of immune modulation therapy in the first Croatian infant diagnosed with Pompe disease: a 3-year follow-up study","volume":"126","author":"Markic","year":"2014","journal-title":"Wien Klin Wochenschr"},{"key":"R25-47-20210226","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ymgme.2012.11.013","article-title":"Low anal sphincter tone in infantile-onset Pompe disease: an emerging clinical issue in enzyme replacement therapy patients requiring special attention","volume":"108","author":"Tan","year":"2013","journal-title":"Mol Genet Metab"},{"key":"R26-47-20210226","doi-asserted-by":"crossref","first-page":"323","DOI":"10.5546\/aap.2012.323","article-title":"Enzyme replacement therapy in the infantile form of Pompe disease: Argentinean experience in a seven-year follow up case","volume":"110","author":"Amartino","year":"2012","journal-title":"Arch Argent Pediatr"},{"key":"R27-47-20210226","first-page":"389","article-title":"Long-term follow-up results in enzyme replacement therapy for Pompe disease: a case report","volume":"33","author":"Del Rizzo","year":"2010","journal-title":"JIMD Rep"},{"key":"R28-47-20210226","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.pediatrneurol.2010.02.006","article-title":"Acute progression of neuromuscular findings in infantile Pompe disease","volume":"42","author":"Burrow","year":"2010","journal-title":"Pediatr Neurol"},{"key":"R29-47-20210226","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/PEC.0b013e3181d6db0a","article-title":"Infantile-onset Pompe disease: a diagnosis not to miss","volume":"26","author":"Dixon","year":"2010","journal-title":"Pediatr Emerg Care"},{"key":"R30-47-20210226","first-page":"474","article-title":"Enzyme replacement therapy for infantile Pompe disease during the critical period and identification of a novel mutation","volume":"15","author":"But","year":"2009","journal-title":"Hong Kong Med J"},{"key":"R31-47-20210226","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1212\/01.wnl.0000319722.16673.27","article-title":"Enzyme replacement therapy for infantile-onset Pompe disease: curse or cure?","volume":"71","author":"Willems","year":"2008","journal-title":"Neurol"},{"key":"R32-47-20210226","first-page":"379","article-title":"Infantile-onset glycogen storage disease type II (Pompe disease): report of a case with genetic diagnosis and pathological findings","volume":"27","author":"Teng","year":"2004","journal-title":"Chang Gung Med J"},{"key":"R33-47-20210226","first-page":"45","article-title":"Adult and infantile glycogenosis type II in one family, explained by allelic diversity","volume":"46","author":"Hoefsloot","year":"1990","journal-title":"Am J Hum Genet"},{"key":"R34-47-20210226","first-page":"323","article-title":"Glycogenosis type II, infantile variant. Report of a case and review of the literature","volume":"56","author":"Garc\u00eda Mendoza","year":"1986","journal-title":"Arch Inst Cardiol Mex"},{"key":"R35-47-20210226","first-page":"245","article-title":"Infantile-acute acid maltase deficiency (Pompe's disease): studies of muscle cultures","volume":"28","author":"Meola","year":"1983","journal-title":"Basic Appl Histochem"},{"key":"R36-47-20210226","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.ymgme.2011.08.003","article-title":"Atypical immunologic response in a patient with CRIM-negative Pompe disease","volume":"104","author":"Abbott","year":"2011","journal-title":"Mol Genet Metab"},{"key":"R37-47-20210226","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1086\/301788","article-title":"The African origin of the common mutation in African American patients with glycogen-storage disease type II","volume":"62","author":"Becker","year":"1998","journal-title":"Am J Hum Genet"},{"key":"R38-47-20210226","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1212\/WNL.55.8.1122","article-title":"Juvenile and adult-onset acid maltase deficiency in France: genotype\u2013phenotype correlation","volume":"55","author":"Lafor\u00eat","year":"2000","journal-title":"Neurology"},{"key":"R39-47-20210226","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/ajmg.c.31318","article-title":"The genotype\u2013phenotype correlation in Pompe disease","volume":"160C","author":"Kroos","year":"2012","journal-title":"Am J Med Genet"},{"key":"R40-47-20210226","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1111\/j.1460-9592.2007.02215.x","article-title":"Cardiac arrhythmias following anesthesia induction in infantile-onset Pompe disease: a case series","volume":"17","author":"Wang","year":"2007","journal-title":"Paediatr Anaesth"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000009186","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,28]],"date-time":"2025-06-28T23:59:20Z","timestamp":1751155160000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201712220-00047"}},"subtitle":["A case report and literature review"],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":38,"journal-issue":{"issue":"51","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000009186","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]}}}